Maximizing Profit and Patient Referrals: 5 Key Strategies for Growing Your Injectables-Only Clinic
Ready to grow your injectables-only clinic and increase both profitability and patient satisfaction? Join LashLOQ for an exclusive session where Mike, a recognized expert in the injectables field, shares 5 proven strategies to expand your clinic’s success.
Learn how to diversify your offerings beyond just toxins and HA fillers by adding new, low-cost, high-reward treatments that will enhance patient satisfaction and drive word-of-mouth referrals. Mike will walk you through actionable steps to integrate these strategies seamlessly into your practice for sustainable growth and increased profitability.
What you'll learn:
5 powerful strategies to boost your clinic’s bottom line
How to diversify your services with low-investment, high-reward options
Effective techniques to increase word-of-mouth referrals
Actionable steps to enhance patient satisfaction and retention
How to stand out in the competitive injectables market
Speaker - Mike Clague, Aesthetic Nurse, BSC, Australia
Mike began his career in medical aesthetics with Allergan, the makers of anti-wrinkle injections and fillers, being educated on techniques from some of the best injectors globally throughout a six-year period. Mike worked with Dr Mauricio De Maio, Dr Michael Kane, Dr Ava Shamban, Dr Mary Lupo, Dr Alastair Carruthers, Dr Jean Carruthers, Dr Herve Respaldo, Dr Steven Liew, Professor Greg Goodman and many more talented ‘OG’ doctors. Basically, he learned from the best of the best.
Mike’s first qualification was his BSC majoring in anatomy at Monash University. In this course, Mike gained a vast insight into human anatomy and physiology through comprehensive theoretical work, and in practice by performing many dissections of cadavers.
In the past 21 years, Mike has trained over 6000 doctors and nurses in the art of injecting both muscle relaxants and dermal fillers across the USA, Australia, New Zealand, Thailand, India, Malaysia and the Philippines in addition to consulting for such well-esteemed companies as Allergan Pharmaceuticals, ALMA lasers, Lutronic, Galderma Pharmaceuticals, FILL MED Art Filler, HUGEL aesthetics, Xytide and Croma Pharmaceuticals Austria. Mike has performed over 40,000 injectable treatments.
Mike is published in 10 peer reviewed medical journals. Recently a consensus on the management of delayed onset nodules.
The most notable of his publications was the first reversal of blindness caused by dermal filler by injecting hyaluronidase deeply into the supra-orbital notch . Notably, this is now accepted as the gold standard for hyaluronic acid dissolving in a visual disturbance event after many other repeated cases vs the inferior retrobulbar injection.
In terms of his practice, Mike is passionate about natural, undetectable results for all of his patients, placing great importance on safe realistic and reliable outcomes